BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 621284)

  • 1. Influence of basal insulin and glucagon secretion on potassium and sodium metabolism. Studies with somatostatin in normal dogs and in normal and diabetic human beings.
    DeFronzo RA; Sherwin RS; Dillingham M; Hendler R; Tamborlane WV; Felig P
    J Clin Invest; 1978 Feb; 61(2):472-9. PubMed ID: 621284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatostatin-induced changes in insulin and glucagon secretion in normal and diabetic dogs.
    Sakurai H; Dobbs R; Unger RH
    J Clin Invest; 1974 Dec; 54(6):1395-402. PubMed ID: 4436439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucose homeostasis during prolonged suppression of glucagon and insulin secretion by somatostatin.
    Sherwin RS; Hendler R; DeFronzo R; Wahren J; Felic P
    Proc Natl Acad Sci U S A; 1977 Jan; 74(1):348-52. PubMed ID: 264686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of physiologic levels of glucagon and growth hormone on human carbohydrate and lipid metabolism. Studies involving administration of exogenous hormone during suppression of endogenous hormone secretion with somatostatin.
    Gerich JE; Lorenzi M; Bier DM; Tsalikian E; Schneider V; Karam JH; Forsham PH
    J Clin Invest; 1976 Apr; 57(4):875-84. PubMed ID: 820717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of intermittent endogenous hyperglucagonemia on glucose homeostasis in normal and diabetic man.
    Rizza R; Verdonk C; Miles J; Service FJ; Gerich J
    J Clin Invest; 1979 Jun; 63(6):1119-23. PubMed ID: 447838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucose disposal during insulinopenia in somatostatin-treated dogs. The roles of glucose and glucagon.
    Shulman GI; Liljenquist JE; Williams PE; Lacy WW; Cherrington AD
    J Clin Invest; 1978 Aug; 62(2):487-91. PubMed ID: 670404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The inhibitory effect of somatostatin on growth hormone, insulin and glucagon secretion in diabetes mellitus.
    Ward FR; Leblanc H; Yen SS
    J Clin Endocrinol Metab; 1975 Sep; 41(3):527-32. PubMed ID: 1159060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for a role of endogenous insulin and glucagon in the regulation of potassium homeostasis.
    Santeusanio F; Faloona GR; Knochel JP; Unger RH
    J Lab Clin Med; 1973 Jun; 81(6):809-17. PubMed ID: 4710366
    [No Abstract]   [Full Text] [Related]  

  • 9. The role of insulin and glucagon in the regulation of basal glucose production in the postabsorptive dog.
    Cherrington AD; Chiasson JL; Liljenquist JE; Jennings AS; Keller U; Lacy WW
    J Clin Invest; 1976 Dec; 58(6):1407-18. PubMed ID: 993351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of insulin and glucagon in oxytocin effects on glucose metabolism.
    Altszuler N; Winkler B; Rosenberg CR; Pi-Sunyer FX; Fuchs AR
    Proc Soc Exp Biol Med; 1992 Feb; 199(2):236-42. PubMed ID: 1346936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin, glucagon, and somatostatin in normal physiology and diabetes mellitus.
    Felig P; Wahren J; Sherwin R; Hendler R
    Diabetes; 1976 Dec; 25(12):1091-9. PubMed ID: 992227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biphasic effect of somatostatin on oral glucose tolerance in maturity-onset diabetes.
    Tamborlane WV; Sherwin RS; Hendler R; Felig P
    Metabolism; 1978 Jul; 27(7):849-53. PubMed ID: 661568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucagon-induced increase in plasma potassium levels in type 1 (insulin-dependent) diabetic subjects.
    Cagliero E; Martina V; Massara F; Molinatti GM
    Diabetologia; 1983 Feb; 24(2):85-7. PubMed ID: 6132848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opposing actions of glucagon and insulin on splanchnic d cell function.
    Kawai K; Unger RH
    J Clin Invest; 1983 Mar; 71(3):721-5. PubMed ID: 6131079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of glucagon in the pathogenesis of the endogenous hyperglycemia of diabetes mellitus.
    Sakurai H; Dobbs RE; Unger RH
    Metabolism; 1975 Nov; 24(11):1287-97. PubMed ID: 1186499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The historic role of insulin in the physiopathology of the metabolic complications from pancreatic diabetes. Therapeutic implications for somatostatin].
    Guillemin R; Fontaine M
    C R Acad Hebd Seances Acad Sci D; 1975 May; 280(20):2353-6. PubMed ID: 807423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of glucagon, catecholamines, and growth hormone in human glucose counterregulation. Effects of somatostatin and combined alpha- and beta-adrenergic blockade on plasma glucose recovery and glucose flux rates after insulin-induced hypoglycemia.
    Rizza RA; Cryer PE; Gerich JE
    J Clin Invest; 1979 Jul; 64(1):62-71. PubMed ID: 36413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of selective insulin or glucagon deficiency on glucose turnover.
    Lickley HL; Ross GG; Vranic M
    Am J Physiol; 1979 Mar; 236(3):E255-62. PubMed ID: 426056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma K plus and insulin: changes during KCl infusion in normal and nephrectomized dogs.
    Pettit GW; Vick RL; Swander AM
    Am J Physiol; 1975 Jan; 228(1):107-9. PubMed ID: 1146998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arginine-stimulated acute phase of insulin and glucagon secretion in diabetic subjects.
    Palmer JP; Benson JW; Walter RM; Ensinck JW
    J Clin Invest; 1976 Sep; 58(3):565-70. PubMed ID: 783201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.